This finding aligns with previous research, such as a study utilizing TCGA data, which reported that high EZH2 expression was associated with poor prognosis in patients with HCC (n = 243) and was correlated with advanced tumor stages and increased recurrence rates24. This evidence concerns the gene EZH2 and hepatocellular carcinoma.